Literature DB >> 11147839

Cytochrome P450 2E1 (CYP2E1)-dependent production of a 37-kDa acetaldehyde-protein adduct in the rat liver.

K S Jeong1, Y Soh, J Jeng, M R Felder, J P Hardwick, B J Song.   

Abstract

Ethanol-inducible cytochrome P450 2E1 (CYP2E1) has been shown to be involved in the metabolism of both ethanol and acetaldehyde. Acetaldehyde, produced from ethanol metabolism, is highly reactive and can form various protein adducts. In this study, we investigated the role of CYP2E1 in the production of a 37-kDa acetaldehyde-protein adduct. Rats were pairfed an isocaloric control or an alcohol liquid diet with and without cotreatment of YH439, an inhibitor of CYP2E1 gene transcription, for 4 weeks. The soluble proteins from rat livers of each group were separated on SDS-polyacrylamide gels followed by immunoblot analysis using specific antibodies against the 37-kDa protein acetaldehyde adduct. In addition, catalytic activities of the enzymes involved in alcohol and acetaldehyde metabolism were measured and compared with the adduct level. Immunoblot analysis revealed that the 37-kDa adduct, absent in the pair-fed control, was evident in alcohol-fed rats but markedly reduced by YH439 treatment. Immunohistochemical analysis also showed that the 37-kDa adduct is predominantly localized in the pericentral region of the liver where CYP2E1 protein is mainly expressed. This staining disappeared in the pericentral region after YH439 treatment. The levels of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase isozymes were unchanged after YH439 treatment. However, the level of the 37-kDa protein adduct positively correlated with the hepatic content of P4502E1. These data indicate that the 37-kDa adduct could be produced by CYP2E1-mediated ethanol metabolism in addition to the ADH-dependent formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11147839     DOI: 10.1006/abbi.2000.2119

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

1.  Inactivation of cytosolic aldehyde dehydrogenase via S-nitrosylation in ethanol-exposed rat liver.

Authors:  Kwan-Hoon Moon; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  FEBS Lett       Date:  2007-07-25       Impact factor: 4.124

Review 2.  ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications.

Authors:  Yingmei Zhang; Jun Ren
Journal:  Pharmacol Ther       Date:  2011-06-12       Impact factor: 12.310

Review 3.  Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.

Authors:  Byoung-Joon Song; Mohamed A Abdelmegeed; Seong-Ho Yoo; Bong-Jo Kim; Sangmee A Jo; Inho Jo; Kwan-Hoon Moon
Journal:  J Proteomics       Date:  2011-05-15       Impact factor: 4.044

4.  Inhibition of mitochondrial aldehyde dehydrogenase by nitric oxide-mediated S-nitrosylation.

Authors:  Kwan-Hoon Moon; Bong-Jo Kim; Byoung J Song
Journal:  FEBS Lett       Date:  2005-10-11       Impact factor: 4.124

5.  Increased oxidation and degradation of cytosolic proteins in alcohol-exposed mouse liver and hepatoma cells.

Authors:  Bong-Jo Kim; Brian L Hood; Richard A Aragon; James P Hardwick; Thomas P Conrads; Timothy D Veenstra; Byoung J Song
Journal:  Proteomics       Date:  2006-02       Impact factor: 3.984

Review 6.  Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer.

Authors:  Yongchao Wang; Mei Xu; Zun-Ji Ke; Jia Luo
Journal:  Pharmacol Res       Date:  2016-12-08       Impact factor: 7.658

7.  A snapshot of the hepatic transcriptome: ad libitum alcohol intake suppresses expression of cholesterol synthesis genes in alcohol-preferring (P) rats.

Authors:  Jonathon D Klein; Jeremy B Sherrill; Gabriella M Morello; Phillip J San Miguel; Zhenming Ding; Suthat Liangpunsakul; Tiebing Liang; William M Muir; Lawrence Lumeng; Amy C Lossie
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 8.  Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications.

Authors:  Byoung-Joon Song; Mohammed Akbar; Mohamed A Abdelmegeed; Kyunghee Byun; Bonghee Lee; Seung Kew Yoon; James P Hardwick
Journal:  Redox Biol       Date:  2014       Impact factor: 11.799

Review 9.  Pharmacogenetic aspects of addictive behaviors.

Authors:  Nadia S Hejazi
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

10.  Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease.

Authors:  Nobuhiko Hayashi; Joseph George; Masayoshi Takeuchi; Atsushi Fukumura; Nobuyuki Toshikuni; Tomiyasu Arisawa; Mikihiro Tsutsumi
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.